Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 513015, 12 pages
http://dx.doi.org/10.1155/2012/513015
Research Article

NFAT5 Contributes to Osmolality-Induced MCP-1 Expression in Mesothelial Cells

1Department of Physiology, University of Munich, 80336 Munich, Germany
2Department of Nephrology, Medical Clinic and Policlinic IV, University of Munich, Inner City Campus, 80335 Munich, Germany

Received 21 December 2011; Accepted 28 January 2012

Academic Editor: Markus Wörnle

Copyright © 2012 Christoph Küper et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Devuyst, N. Topley, and J. D. Williams, “Morphological and functional changes in the dialysed peritoneal cavity: impact of more biocompatible solutions,” Nephrology Dialysis Transplantation, vol. 17, supplement 3, pp. 12–15, 2002. View at Google Scholar · View at Scopus
  2. C. W. McIntyre, “Update on peritoneal dialysis solutions,” Kidney International, vol. 71, no. 6, pp. 486–490, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. D. Williams, K. J. Craig, N. Topley et al., “Morphologic changes in the peritoneal membrane of patients with renal disease,” Journal of the American Society of Nephrology, vol. 13, no. 2, pp. 470–479, 2002. View at Google Scholar · View at Scopus
  4. P. M. Ter Wee and F. J. Van Ittersum, “The new peritoneal dialysis solutions: friends only, or foes in part?” Nature Clinical Practice Nephrology, vol. 3, no. 11, pp. 604–612, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. T. O. Bender, J. Witowski, C. Aufricht et al., “Biocompatibility of a bicarbonate-buffered amino-acid-based solution for peritoneal dialysis,” Pediatric Nephrology, vol. 23, no. 9, pp. 1537–1543, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Fabbrini, M. Zareie, P. M. ter Wee, E. D. Keuning, R. H. J. Beelen, and J. van den Born, “Peritoneal exposure model in the rat as a tool to unravel bio(in)compatibility of PDF,” Nephrology Dialysis Transplantation, vol. 21, no. 2, pp. ii8–ii11, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Y. H. Wong, A. O. Phillips, J. Witowski, and N. Topley, “Glucose-mediated induction of TGF-β1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent,” Kidney International, vol. 63, no. 4, pp. 1404–1416, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Miyakawa, S. K. Woo, S. C. Dahl, J. S. Handler, and H. M. Kwon, “Tonicity-responsive enhancer binding protein, a Rel-like protein that stimulates transcription in response to hypertonicity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 5, pp. 2538–2542, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Neuhofer and F. X. Beck, “Cell survival in the hostile environment of the renal medulla,” Annual Review of Physiology, vol. 67, pp. 531–555, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Y. Go, X. Liu, M. A. Roti, F. Liu, and S. N. Ho, “NFATS/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 29, pp. 10673–10678, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Neuhofer, “Role of NFAT5 in inflammatory disorders associated with osmotic stress,” Current Genomics, vol. 11, no. 8, pp. 584–590, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Roth, V. Leroy, H. M. Kwon, P. Y. Martin, E. Féraille, and U. Hasler, “Osmoprotective transcription factor NFAT5/TonEBP modulates nuclear factor-κB activity,” Molecular Biology of the Cell, vol. 21, no. 19, pp. 3459–3474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Kojima, H. Taniguchi, A. Tsuzuki, K. Nakamura, Y. Sakakura, and M. Ito, “Hypertonicity-induced expression of monocyte chemoattractant protein-1 through a novel Cis-acting element and MAPK signaling pathways,” Journal of Immunology, vol. 184, no. 9, pp. 5253–5262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Yoshimura, N. Yuhki, S. K. Moore, E. Appella, M. I. Lerman, and E. J. Leonard, “Human monocyte chemoattractant protein-1 (MCP-1). Full length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE,” FEBS Letters, vol. 244, no. 2, pp. 487–493, 1989. View at Publisher · View at Google Scholar · View at Scopus
  15. F. K. Li, A. Davenport, R. L. Robson et al., “Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression,” Kidney International, vol. 54, no. 6, pp. 2170–2183, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Jiang, D. I. Beller, G. Frendl, and D. T. Graves, “Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes,” Journal of Immunology, vol. 148, no. 8, pp. 2423–2428, 1992. View at Google Scholar · View at Scopus
  17. B. J. Rollins, A. Walz, and M. Baggiolini, “Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes,” Blood, vol. 78, no. 4, pp. 1112–1116, 1991. View at Google Scholar · View at Scopus
  18. M. Gharaee-Kermani, E. M. Denholm, and S. H. Phan, “Costimulation of fibroblast collagen and transforming growth factor β1 gene expression by monocyte chemoattractant protein-1 via specific receptors,” The Journal of Biological Chemistry, vol. 271, no. 30, pp. 17779–17784, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Inoshima, K. Kuwano, N. Hamada et al., “Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice,” American Journal of Physiology, vol. 286, no. 5, pp. L1038–L1044, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Marra, R. DeFranco, C. Grappone et al., “Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration,” American Journal of Pathology, vol. 152, no. 2, pp. 423–430, 1998. View at Google Scholar · View at Scopus
  21. C. M. Lloyd, M. E. Dorf, A. Proudfoot, D. J. Salant, and J. C. Gutierrez-Ramos, “Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis,” Journal of Leukocyte Biology, vol. 62, no. 5, pp. 676–680, 1997. View at Google Scholar · View at Scopus
  22. H. B. Zeyneloglu, L. M. Senturk, E. Seli, E. Oral, D. L. Olive, and A. Arici, “The role of monocyte chemotactic protein-1 in intraperitoneal adhesion formation,” Human Reproduction, vol. 13, no. 5, pp. 1194–1199, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. H. B. Zeyneloglu, E. Seli, L. M. Senturk, L. S. Gutierrez, D. L. Olive, and A. Arici, “The effect of monocyte chemotactic protein 1 in intraperitoneal adhesion formation in a mouse model,” American Journal of Obstetrics and Gynecology, vol. 179, no. 2, pp. 438–443, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. C. E. Visser, J. Tekstra, J. J. E. Brouwer-Steenbergen et al., “Chemokines produced by mesothelial cells: huGRO-α, IP-10, MCP-1 and RANTES,” Clinical and Experimental Immunology, vol. 112, no. 2, pp. 270–275, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Takahashi, Y. Taniguchi, A. Nakashima et al., “Mizoribine suppresses the progression of experimental peritoneal fibrosis in a rat model,” Nephron, vol. 112, no. 2, pp. e59–e69, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S. K. Lee, B. S. Kim, W. S. Yang, S. B. Kim, S. K. Park, and J. S. Park, “High glucose induces MCP-1 expression partly via tyrosine kinase-AP-1 pathway in peritoneal mesothelial cells,” Kidney International, vol. 60, no. 1, pp. 55–64, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Matsuo, M. Tamura, N. Kabashima et al., “Prednisolone inhibits hyperosmolarity-induced expression of MCP-1 via NF-κB in peritoneal mesothelial cells,” Kidney International, vol. 69, no. 4, pp. 736–746, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Neuhofer, D. Steinert, M. L. Fraek, and F. X. Beck, “Prostaglandin E2 stimulates expression of osmoprotective genes in MDCK cells and promotes survival under hypertonic conditions,” Journal of Physiology, vol. 583, no. 1, pp. 287–297, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Küper, D. Steinert, M. L. Fraek, F. X. Beck, and W. Neuhofer, “EGF receptor signaling is involved in expression of osmoprotective TonEBP target gene aldose reductase under hypertonic conditions,” American Journal of Physiology, vol. 296, no. 5, pp. F1100–F1108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. J. D. Ferraris, C. K. Williams, P. Persaud, Z. Zhang, Y. Chen, and M. B. Burg, “Activity of the TonEBP/OREBP transactivation domain varies directly with extracellular NaCl concentration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 2, pp. 739–744, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. Q. Cai, J. D. Ferraris, and M. B. Burg, “High NaCl increases TonEBP/OREBP mRNA and protein by stabilizing its mRNA,” American Journal of Physiology, vol. 289, no. 4, pp. F803–F807, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Gallazzini, M. J. Yu, R. Gunaratne, M. B. Burg, and J. D. Ferraris, “c-Abl mediates high NaCl-induced phosphorylation and activation of the transcription factor TonEBP/OREBP,” The FASEB Journal, vol. 24, no. 11, pp. 4325–4335, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. S. C. Dahl, J. S. Handler, and H. M. Kwon, “Hypertonicity-induced phosphorylation and nuclear localization of the transcription factor TonEBP,” American Journal of Physiology, vol. 280, no. 2, pp. C248–C253, 2001. View at Google Scholar · View at Scopus
  34. C. E. Irarrazabal, M. Gallazzini, M. P. Schnetz et al., “Phospholipase C-γ1 is involved in signaling the activation by high NaCl of the osmoprotective transcription factor TonEBP/OREBP,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 2, pp. 906–911, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Neuhofer, C. Küper, M.-L. Fraek et al., “Focal Adhesion Kinase regulates TonEBP transcriptional activity in response to osmotic stress,” Acta Physiologica, vol. 201, supplement 682, article 248, 2011. View at Google Scholar
  36. M. Tamura, A. Osajima, S. Nakayamada et al., “High glucose levels inhibit focal adhesion kinase-mediated wound healing of rat peritoneal mesothelial cells,” Kidney International, vol. 63, no. 2, pp. 722–731, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Ha, M. R. Yu, H. N. Choi et al., “Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation,” Peritoneal Dialysis International, vol. 20, supplement 5, pp. S10–S18, 2001. View at Google Scholar
  38. C. Küper, F. X. Beck, and W. Neuhofer, “Osmoadaptation of mammalian cells—an orchestrated network of protective genes,” Current Genomics, vol. 8, no. 4, pp. 209–218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Jiang, A. J. Valente, M. J. Williamson, L. Zhang, and D. T. Graves, “Post-translational modification of a monocyte-specific chemoattractant synthesized by glioma, osteosarcoma, and vascular smooth muscle cells,” The Journal of Biological Chemistry, vol. 265, no. 30, pp. 18318–18321, 1990. View at Google Scholar · View at Scopus
  40. P. Proost, S. Struyf, M. Couvreur et al., “Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor,” Journal of Immunology, vol. 160, no. 8, pp. 4034–4041, 1998. View at Google Scholar · View at Scopus
  41. P. Ruggiero, S. Flati, V. Di Cioccio et al., “Glycosylation enhances functional stability of the chemotactic cytokine CCL2,” European Cytokine Network, vol. 14, no. 2, pp. 91–96, 2003. View at Google Scholar · View at Scopus
  42. H. J. Goldberg, C. I. Whiteside, G. W. Hart, and I. G. Fantus, “Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells,” Endocrinology, vol. 147, no. 1, pp. 222–231, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. I. Han and J. E. Kudlow, “Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility,” Molecular and Cellular Biology, vol. 17, no. 5, pp. 2550–2558, 1997. View at Google Scholar · View at Scopus
  44. S. K. Woo, S. C. Dahl, J. S. Handler, and H. M. Kwon, “Bidirectional regulation of tonicity-responsive enhancer binding protein in response to changes in tonicity,” American Journal of Physiology, vol. 278, no. 6, pp. F1006–F1012, 2000. View at Google Scholar · View at Scopus
  45. B. Yang, A. D. Hodgkinson, P. J. Oates, M. K. Hyug, B. A. Millward, and A. G. Demaine, “Elevated activity of transcription factor nuclear factor of activated T-cells 5 (NFAT5) and diabetic nephropathy,” Diabetes, vol. 55, no. 5, pp. 1450–1455, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. S. J. Davies, G. Woodrow, K. Donovan et al., “Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial,” Journal of the American Society of Nephrology, vol. 14, no. 9, pp. 2338–2344, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Freida, M. Wilkie, S. Jenkins, F. Dallas, and B. Issad, “The contribution of combined crystalloid and colloid osmosis to fluid and sodium management in peritoneal dialysis,” Kidney International, vol. 73, no. 108, pp. S102–S111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. N. M. Selby, J. Fialova, J. O. Burton, and C. W. McIntyre, “The haemodynamic and metabolic effects of hypertonic-glucose and amino-acid-based peritoneal dialysis fluids,” Nephrology Dialysis Transplantation, vol. 22, no. 3, pp. 870–879, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. C. López-Rodríguez, J. Aramburu, L. Jin, A. S. Rakeman, M. Michino, and A. Rao, “Bridging the NFAT and NF-κB families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress,” Immunity, vol. 15, no. 1, pp. 47–58, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Zemel, G. C. M. Koomen, A. A. M. Hart, I. J. M. ten Berge, D. G. Struijk, and R. T. Krediet, “Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis,” Journal of Laboratory and Clinical Medicine, vol. 122, no. 6, pp. 686–696, 1993. View at Google Scholar · View at Scopus
  51. R. K. Mackenzie, C. J. Holmes, A. Moseley et al., “Bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage tnfα secretion,” Journal of the American Society of Nephrology, vol. 9, no. 8, pp. 1499–1506, 1998. View at Google Scholar · View at Scopus
  52. S. K. Woo, S. D. Lee, K. Y. Na, W. K. Park, and H. M. Kwon, “TonEBP/NFAT5 stimulates transcription of HSP70 in response to hypertonicity,” Molecular and Cellular Biology, vol. 22, no. 16, pp. 5753–5760, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Arbeiter, B. Bidmon, M. Endemann et al., “Induction of mesothelial HSP-72 upon in vivo exposure to peritoneal dialysis fluid,” Peritoneal Dialysis International, vol. 23, no. 5, pp. 499–501, 2003. View at Google Scholar · View at Scopus
  54. C. Aufricht, M. Endemann, B. Bidmon et al., “Peritoneal dialysis fluids induce the stress response in human mesothelial cells,” Peritoneal Dialysis International, vol. 21, no. 1, pp. 85–88, 2001. View at Google Scholar · View at Scopus
  55. B. Bidmon, M. Endemann, K. Arbeiter et al., “Overexpression of HSP-72 confers cytoprotection in experimental peritoneal dialysis,” Kidney International, vol. 66, no. 6, pp. 2300–2307, 2004. View at Publisher · View at Google Scholar · View at Scopus